DDIT3 and neoplasm: We first tested the FL first-line treatment R-CHOP, and we observed an induction of tumor cell depletion above 80% in 9 out of 11 FL-PDLS (81%) (Fig. 4B, Figure S7A) that is consistent with the observed response rate in the clinical practice [42].